InnoBooster grant from Innovation Fund Denmark

Scandion Oncology has been awarded an InnoBoster grant from Innovation Fund Denmark to conduct further research with its leading drug SCO-101.

Co-funded by the Horizon 2020 programme of the European Union
Co-funded by the COSME programme of the European Union